AstraZeneca advances mass global rollout of COVID-19 vaccine through COVAX
Supply to 142 countries underway as part of the unprecedented effort to bring broad and equitable access to the vaccine AstraZeneca with its partner Serum Institute of India will be the biggest initial supplier to COVAXThe first of many millions of doses of AstraZeneca’s COVID-19 vaccine have begun arriving in low and middle-income countries across the world through the multilateral COVAX initiative, the first steps in fulfilling the Company’s efforts to provide broad and equitable access to the vaccine. First COVAX shipments were dispatched late last week to Ghana and Cote D’Ivoire,